Zanubrutinib,Ibrutinib
beigene,abbvie,janssen
['lymphoma', 'zanu ', 'leusm', 'lymsm', 'cml', 'ibru']
great data from #17icml that lymphoma docs can use to counsel about zanu vs ibrutinib. regardless of the btk inhibitor, there is improvement in overall qol and physical/role function, as well as ongoing improvement in fatigue, pain, and diarrhea up to 1 year. #lymsm #leusm 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈